IN2014MN01733A - - Google Patents

Info

Publication number
IN2014MN01733A
IN2014MN01733A IN1733MUN2014A IN2014MN01733A IN 2014MN01733 A IN2014MN01733 A IN 2014MN01733A IN 1733MUN2014 A IN1733MUN2014 A IN 1733MUN2014A IN 2014MN01733 A IN2014MN01733 A IN 2014MN01733A
Authority
IN
India
Prior art keywords
composition
relates
present
hibiscus
salt
Prior art date
Application number
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN01733(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of IN2014MN01733A publication Critical patent/IN2014MN01733A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

The present invention relates to a composition comprising at least one protein extract of hibiscus and/or at least one beta glucan or a salt thereof. Furthermore the present invention relates to the use of said composition for the treatment of anal rhagades.
IN1733MUN2014 2012-01-30 2012-01-30 IN2014MN01733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
IN2014MN01733A true IN2014MN01733A (en) 2015-07-10

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1733MUN2014 IN2014MN01733A (en) 2012-01-30 2012-01-30

Country Status (24)

Country Link
US (1) US9345747B2 (en)
EP (1) EP2646039B1 (en)
JP (1) JP5903505B2 (en)
KR (1) KR101599447B1 (en)
CN (2) CN104114177A (en)
AU (1) AU2012368815B2 (en)
BR (1) BR112014018850A8 (en)
CA (1) CA2863369C (en)
DK (1) DK2646039T3 (en)
ES (1) ES2485490T3 (en)
HK (1) HK1186378A1 (en)
HR (1) HRP20140594T1 (en)
IL (1) IL233875A (en)
IN (1) IN2014MN01733A (en)
MX (1) MX336204B (en)
PL (1) PL2646039T3 (en)
RS (1) RS53457B (en)
RU (1) RU2580622C2 (en)
SA (1) SA113340239B1 (en)
SG (1) SG11201404413UA (en)
SI (1) SI2646039T1 (en)
TW (1) TWI495476B (en)
WO (1) WO2013114410A1 (en)
ZA (1) ZA201405208B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6523291B2 (en) 2013-12-24 2019-05-29 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Cosmetic composition and method for providing high penetration of skin care active ingredients
ITRM20150163A1 (en) * 2015-04-17 2016-10-17 Uniderm Farm S R L PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ANAL RADIUS
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
EP3787654A4 (en) * 2018-05-02 2022-04-20 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (en) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Pharmaceutical composition in the form of an ointment for the treatment of hemorrhoids

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
AU7340098A (en) 1997-04-16 1998-11-11 Laboratoires Serobiologiques (Societe Anonyme) Use in cosmetics of a protein fraction extracted from okra seeds
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (en) * 1998-04-28 1999-11-03 王京杭 Tissue restoration accelerator
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (en) * 2000-11-09 2002-07-23 Onaka Yasushi APPLICATION OF beta-1,3-1,6-GLUCAN (AUREOBASIDIUM CULTURE SOLUTION) IN VARIOUS INDUSTRIAL FIELDS INCLUDING MEDICAL, HEALTH WELFARE AND FOOD INDUSTRIES
JP2003104832A (en) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk Skin care preparation
JP4544500B2 (en) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 Hyaluronic acid synthesis accelerator
PT1622627E (en) * 2003-05-02 2013-06-04 Ceapro Inc Pharmaceutical compositions comprising cereal beta(1-3) beta(1-4) glucan
RU2277920C2 (en) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Method for treating children in case of chronic viral hepatitis at applying sulfide baths and low-carbonate mineral water
ITMI20042111A1 (en) * 2004-11-04 2005-02-04 Biofarmitalia Spa PATCH CONTAINING A CHOSEN SUBSTANCE BETWEEN CATRAMS HAVING REDUCING CHARACTERISTICS IN DERMATOLOGY
JP5048935B2 (en) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 Moisturizer
DE202007004856U1 (en) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. Composition, useful to inhibit aging of skin, comprises chitin, beta-1,3/1,6D glucan and melanin complex; hyaluronic acid and myoxinol as active substance
CN101095482B (en) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 Method for preparing barley wheat bran or oat wheat bran for the preparation of fibre foodstuff
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (en) * 2010-06-09 2011-12-10 Farma Derma S R L PREPARATION FOR VAGINAL AND RECTAL USE AND ITS PRODUCTION PROCEDURE
CN102084963A (en) * 2010-09-29 2011-06-08 吉林省农业机械研究院 Method for preparing oat bran dietary fiber food

Also Published As

Publication number Publication date
EP2646039A1 (en) 2013-10-09
CA2863369A1 (en) 2013-08-08
RU2580622C2 (en) 2016-04-10
SI2646039T1 (en) 2014-10-30
PL2646039T3 (en) 2014-10-31
AU2012368815A1 (en) 2014-09-18
ES2485490T3 (en) 2014-08-13
RS53457B (en) 2014-12-31
US9345747B2 (en) 2016-05-24
BR112014018850A8 (en) 2017-07-11
JP5903505B2 (en) 2016-04-13
EP2646039B1 (en) 2014-05-14
KR101599447B1 (en) 2016-03-14
TW201334787A (en) 2013-09-01
HK1186378A1 (en) 2014-03-14
WO2013114410A1 (en) 2013-08-08
MX336204B (en) 2016-01-11
AU2012368815B2 (en) 2018-03-01
ZA201405208B (en) 2015-10-28
BR112014018850A2 (en) 2017-06-20
HRP20140594T1 (en) 2014-10-24
JP2015504915A (en) 2015-02-16
CN109865000A (en) 2019-06-11
RU2014129391A (en) 2016-03-27
IL233875A0 (en) 2014-09-30
MX2014009244A (en) 2015-03-19
IL233875A (en) 2017-01-31
SG11201404413UA (en) 2014-10-30
CA2863369C (en) 2020-03-10
TWI495476B (en) 2015-08-11
KR20140127296A (en) 2014-11-03
US20140303094A1 (en) 2014-10-09
DK2646039T3 (en) 2014-08-11
CN104114177A (en) 2014-10-22
SA113340239B1 (en) 2015-07-07

Similar Documents

Publication Publication Date Title
HK1215378A1 (en) Pharmaceutical composition, methods for treating and uses thereof
IL246252A0 (en) Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2020009223A (en) Afucosylated anti-fgfr2iiib antibodies.
HK1220324A1 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EA201491766A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
PL3082831T3 (en) Compositions comprising methyl-cyclodextrines to treat or prevent diseases by enhancement of the hdl-cholesterol level
IN2015DN03327A (en)
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
IN2014MN01733A (en)
PL3041831T3 (en) Alpha-tea salt forms: compositions and uses for treating disease
CL2014002817A1 (en) Anamorelin monohydrochloride compound that has controlled chloride content; composition that includes it; compound preparation procedure.
EP3020399A4 (en) Novel pharmaceutical composition for preventing or treating cancer
EP2964750A4 (en) Methods and compositions for the treatment and/or prevention of type 1 diabetes
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
EP2847161A4 (en) Compositions and methods for the treatment of diabetes
HRP20181445T1 (en) Compositions and methods for treatment of type 1 diabetes
MX360885B (en) New antifungal compositions.
EA201690709A1 (en) APPLICATION OF ODIPARTSIL IN THE TREATMENT OF MUCOPOLYSACCHARIDOSIS
IN2014DN10683A (en)
IN2013CH00453A (en)
TN2014000207A1 (en) Anti il-36r antibodies